2023-08-01 16:14:45 ET
- Inspire Medical Systems press release ( NYSE: INSP ): Q2 GAAP EPS of -$0.41 beats by $0.17 .
- Revenue of $151.1M (+65.3% Y/Y) beats by $14.61M .
-
Full Year 2023 Guidance
-
Given the positive trends during the second quarter, Inspire is increasing its full year 2023 revenue guidance to between $600 million to $610 million, which would represent growth of 47% to 50% over full year 2022 revenue of $407.9 million. This compares to the prior revenue guidance of $580 million to $590 million.
-
The Company is maintaining its full year 2023 gross margin guidance of 83% to 85%.
-
Inspire is also maintaining its guidance relating to the opening of new U.S. medical centers of 52 to 56 per quarter for the remainder of 2023, as well as its guidance of 12 to 14 new U.S. territories per quarter for the remainder of 2023.
For further details see:
Inspire Medical Systems GAAP EPS of -$0.41 beats by $0.17, revenue of $151.1M beats by $14.61M